Page last updated: 2024-08-24

capecitabine and Dysarthosis

capecitabine has been researched along with Dysarthosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bayram, E; Bicakci, S; Demir, T; Iscan, D; Tolay, R1
Brandsma, D; De Jong, FA; Hamberg, P; Sleijfer, S; Verweij, J1

Reviews

1 review(s) available for capecitabine and Dysarthosis

ArticleYear
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Agents, Phytogenic; Ataxia; Camptothecin; Capecitabine; Central Nervous System; Colorectal Neoplasms; Cytotoxins; Deoxycytidine; Dexamethasone; Dysarthria; Female; Fluorouracil; Granisetron; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Sarcoma, Small Cell; Serotonin Antagonists; Topoisomerase I Inhibitors

2008

Other Studies

1 other study(ies) available for capecitabine and Dysarthosis

ArticleYear
Capecitabine-related neurotoxicity presenting with agraphia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:3

    Topics: Adult; Agraphia; Capecitabine; Dysarthria; Fluorouracil; Humans; Leukoencephalopathies; Male

2023